Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (391-400 of 531) with videos related to

Pageof 54
Sort By:
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureusRazieh Kebriaei, Katherine Lev, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?Kimberly C Claeys, Abdalhamid M Lagnf, Jessica A Hallesy, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2023
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant <i>Pseudomonas aeruginosa</i> in <i>ex vivo</i> simulated endocardial vegetation modelsAmer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, et al.
Infectious Diseases and Therapy|February 21, 2019
Diagnostic Stewardship: A Clinical Decision Rule for Blood Cultures in Community-Onset Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue InfectionsSarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research NetworkNathaniel J Rhodes, Jamie L Wagner, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous VancomycinEvan J Zasowski, Kyle P Murray, Trang D Trinh, et al.
Journal of Clinical Microbiology|July 18, 2008
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)Michael J Rybak, Steve N Leonard, Kerri L Rossi, et al.
International Journal of Antimicrobial Agents|April 14, 2020
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitalsJamie L Wagner, Nathaniel J Rhodes, Marc H Scheetz, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2014
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypesKatie E Barber, Brian J Werth, Cortney E Ireland, et al.
Pageof 54

Showing results (391-400 of 531) with videos related to

Sort By:
Pageof 54
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureusRazieh Kebriaei, Katherine Lev, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?Kimberly C Claeys, Abdalhamid M Lagnf, Jessica A Hallesy, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2023
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant <i>Pseudomonas aeruginosa</i> in <i>ex vivo</i> simulated endocardial vegetation modelsAmer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, et al.
Infectious Diseases and Therapy|February 21, 2019
Diagnostic Stewardship: A Clinical Decision Rule for Blood Cultures in Community-Onset Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue InfectionsSarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research NetworkNathaniel J Rhodes, Jamie L Wagner, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous VancomycinEvan J Zasowski, Kyle P Murray, Trang D Trinh, et al.
Journal of Clinical Microbiology|July 18, 2008
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)Michael J Rybak, Steve N Leonard, Kerri L Rossi, et al.
International Journal of Antimicrobial Agents|April 14, 2020
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitalsJamie L Wagner, Nathaniel J Rhodes, Marc H Scheetz, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2014
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypesKatie E Barber, Brian J Werth, Cortney E Ireland, et al.
Pageof 54